Zobrazeno 1 - 10
of 116
pro vyhledávání: '"398"'
Autor:
Alison Conlin, William L. Redmond, Staci Mellinger, Sasha E. Stanton, Nicole Moxon, Yaping Wu, Janet Ruzich, Parvin Peddi, David L. Page, Zhaoyu Sun, Katherine Sanchez, Kelly Shea Perlewitz
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A430-A430
BackgroundBackground: The FDA has approved pembrolizumab in combination with neoadjuvant chemotherapy (doxorubicin, cyclophosphamide, paclitaxel [ACT], and carboplatin) for stage II/III TNBC, on the basis of improved event free survival (EFS) and pat
Publikováno v:
Toxicology and Applied Pharmacology. 401:115114
Autor:
Scott M. Hammer, Line Labbé, Marc Pfister, Kara Bennett, Susan L. Rosenkranz, John W. Mellors, Lewis B. Sheiner
Publikováno v:
Antimicrobial Agents and Chemotherapy. 47:130-137
The present population pharmacokinetic (PK) and pharmacodynamic (PD) study modeled the effects of covariates including drug adherence and the coadministration of protease inhibitors (PIs) on the pharmacokinetics of efavirenz (EFV) and the relationshi
Publikováno v:
Neuroscience Letters. 248:25-28
Prostaglandins (PGs) are known to be involved in inflammatory and nociceptive processing. Since the discovery of at least two isozymes of cyclooxygenase (COX), inhibition of COX-2 has been suggested to be responsible for the therapeutic effects of no
Publikováno v:
The European journal of neuroscience. 21(1)
BTS 74 398 (1-[1-(3,4-dichlorophenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone monocitrate) is a monoamine reuptake inhibitor that reverses motor deficits in MPTP-treated (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) common marmosets with
Autor:
Sandrine Faivre, M.E. Riveiro, A. de Gramont, A. Raballand, P. Ruszniewski, Pascal Hammel, Eric Raymond, L. Astorgues-Xerri, M. Serova, Cindy Neuzillet
Publikováno v:
European Journal of Cancer. 48:121
Publikováno v:
Vision Research. 35
Autor:
I. Graf
Publikováno v:
Pharmazie in Unserer Zeit. 20:44-44
Autor:
S. Suganuma, H. Matsumoto
Publikováno v:
Biochemical Pharmacology. 8:118
Autor:
Luc Tran, X. Anton Alvarez, Hoang-Anh Le, Dat-Anh Nguyen, Thinh Le, Ngoc Nguyen, Thang Nguyen, Tai Nguyen, Tan Vo, Tuan Tran, Chinh Duong, Huyen Nguyen, Sam Nguyen, Hien Nguyen, Thanh Le, Minh Nguyen
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 21:621-630
Aims: To investigate the efficacy and safety of Cerebrolysin and Cerebrolysin plus nootropics in the routine treatment of patients with acute ischemic stroke (AIS). Background: Acute ischemic stroke (AIS) is a leading cause of disability with unmet t